{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T17:11:56Z","timestamp":1784740316893,"version":"3.55.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T00:00:00Z","timestamp":1578009600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Cysteine-cysteine chemokine receptor 5 is the main HIV co-receptor involved in the virus and cell-to-cell spread. A variant of the CCR5 gene known as CCR5-\u039432 which is a product of 32 base pair deletion in the gene plays critical role in the infection and progression to AIDS. The study was carried out to determine the CCR5 genotype of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 100 subjects attending HIV clinic, University of Calabar Teaching Hospital were purposively recruited for this study. DNA was extracted from each sample using the Quick gDNA miniprep DNA extraction kit, Zymo Research. Polymerase chain reaction (PCR) was used in the amplification of CCR5 gene in each DNA in a 9700 ABI Thermo cycler and then resolved on 4% agarose gel electrophoresis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Result<\/jats:title>\n                    <jats:p>Out of the 100 samples assessed, 100 (100%) were homozygous for the CCR5 wild type gene (CCR5-wt), while none (0%) was homozygous for the CCR5-\u039432 (mutant type), and heterozygosity was not observed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study observed absence of CCR5-\u039432 deletion gene among the studied subjects in Calabar, implying lack of genetic advantage in HIV infection and possible rapid progression towards AIDS if other precautions are not checked.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-019-4737-1","type":"journal-article","created":{"date-parts":[[2020,1,3]],"date-time":"2020-01-03T11:03:11Z","timestamp":1578049391000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cysteine-cysteine chemokine receptor 5 (CCR5) profile of HIV-infected subjects attending University of Calabar Teaching Hospital, Calabar, Southern Nigeria"],"prefix":"10.1186","volume":"20","author":[{"given":"Ekerette Friday","family":"Ekere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monday F.","family":"Useh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2658-3788","authenticated-orcid":false,"given":"Henshaw Uchechi","family":"Okoroiwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatfeng Youtchou","family":"Mirabeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,3]]},"reference":[{"key":"4737_CR1","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.imr.2018.01.008","volume":"7","author":"EA Asemota","year":"2018","unstructured":"Asemota EA, Okafor IM, Okoroiwu HU, Ekong ER, Anyanwu SO, Effiong EE, et al. Zinc, copper, CD4 T \u2013 cell count and some hematological parameters of HIV \u2013 infected subjects in southern Nigeria. Integr Med Res. 2018;7:53\u201360.","journal-title":"Integr Med Res"},{"key":"4737_CR2","unstructured":"World Health Organization (WHO). Global Health Observation (GHO) data: HIV\/AIDS. Available at: www.who.gho\/hiv\/en. Accessed 26 May 2019."},{"key":"4737_CR3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1186\/s12889-018-5555-x","volume":"18","author":"HU Okoroiwu","year":"2018","unstructured":"Okoroiwu HU, Okafor IM, Asemota EA, Okpokam DC. Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation. BMC Public Health. 2018;18:645.","journal-title":"BMC Public Health"},{"key":"4737_CR4","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1186\/s12879-019-4562-6","volume":"19","author":"SB Coco-Bassey","year":"2019","unstructured":"Coco-Bassey SB, Asemota EA, Okoroiwu HU, Etura JE, Efiong EE, Inyang IJ, et al. Glutathione, glutathione peroxidase and some hematological parameters of HIV-seropositive subjects attending clinic in University of Calabar Teaching Hospital, Calabar, Nigeria. BMC Infect Dis. 2019;19:944.","journal-title":"BMC Infect Dis"},{"key":"4737_CR5","unstructured":"Joint United Nations Programme on HIV and AIDs (UNAIDS). The Gap report: children and pregnant women living with HIV. Geneva: UNAIDS; 2014."},{"key":"4737_CR6","volume-title":"Country fact sheets; Nigeria","author":"Joint United Nations programme on HIV and AIDs (UNAIDS)","year":"2017","unstructured":"Joint United Nations programme on HIV and AIDs (UNAIDS). Country fact sheets; Nigeria. 2017. Available at: www.unaids.org\/en\/regionscountries\/nigeria. Accessed 26 May 2019."},{"key":"4737_CR7","volume-title":"Country fast sheets; South Africa","author":"Joint United Nations Programme on HIV and AIDs (UNAIDS)","year":"2017","unstructured":"Joint United Nations Programme on HIV and AIDs (UNAIDS). Country fast sheets; South Africa. 2017. Available at: www.unaids.org\/en\/regionscountries\/southafrica. Accessed 26 May 2019."},{"issue":"9","key":"4737_CR8","first-page":"1","volume":"3","author":"AC Nsonwu-Anyanwu","year":"2017","unstructured":"Nsonwu-Anyanwu AC, Ighodalo EV, King D, Agu CE, Jeremiah S, Solomon OT, et al. Biomarken of oxidative stress in HIV seropositive individuals on highly active antiretroviral therapy. Reactive Oxygen Species. 2017;3(9):1\u201311.","journal-title":"Reactive Oxygen Species"},{"key":"4737_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.mjafi.2015.07.005","volume":"722","author":"CP Roy","year":"2016","unstructured":"Roy CP, Chakrabarti S. Mutation in AIDS restriction gene affecting the HIV infection and disease progression in a high risk group from northeastern India. Med J Armed Forces India. 2016;722:111\u20135.","journal-title":"Med J Armed Forces India"},{"key":"4737_CR10","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1097\/00002030-199408000-00014","volume":"8","author":"SP Buchbinder","year":"1994","unstructured":"Buchbinder SP, Katz MH, Hessol NA, O\u2019Malley PM, Holmberg SD. Long-term HIV-1 infection without immunologic progression. AIDS. 1994;8:1123\u20138.","journal-title":"AIDS"},{"issue":"90001","key":"4737_CR11","doi-asserted-by":"publisher","first-page":"9R","DOI":"10.1093\/hmg\/ddh075","volume":"13","author":"C. Winkler","year":"2004","unstructured":"Winkler C, Ping AN, Stephen J, Brien O. Patterns of ethnic diversity among the genes that influence AIDS. Hum Mol Gent. 2004;13(1):R1\u2013R19.","journal-title":"Human Molecular Genetics"},{"key":"4737_CR12","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/382722a0","volume":"382","author":"M Samson","year":"1996","unstructured":"Samson M, Libert F, Doranz BJ, et al. Resistance to HIV-1 infection in Caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature. 1996;382:722\u20135.","journal-title":"Nature"},{"key":"4737_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/ng1369","volume":"36","author":"SJ O\u2019Brien","year":"2004","unstructured":"O\u2019Brien SJ, Nelson GW. Human genes that limit AIDS. Nat Genet. 2004;36:565\u201374.","journal-title":"Nat Genet"},{"key":"4737_CR14","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0092-8674(00)80110-5","volume":"86","author":"R Liu","year":"1996","unstructured":"Liu R, Paxton WA, Choe S, et al. Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply \u2013 exposed individuals to HIV-1 infection. Cell. 1996;86:367\u2013717.","journal-title":"Cell"},{"key":"4737_CR15","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.humimm.2017.10.001","volume":"78","author":"UV Solloch","year":"2017","unstructured":"Solloch UV, Lang K, Lang V, Bohne I, Shmidt AH. Frequencies of gene variant CCR5-\u220632 in 87 countries based on next generation sequencing of 1.3 million individuals sampled from 3 national DKMS donor centres. Hum Immunol. 2017;78:710\u20137.","journal-title":"Hum Immunol"},{"key":"4737_CR16","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1084\/jem.185.9.1681","volume":"185","author":"L Wu","year":"1997","unstructured":"Wu L, Paxton WA, Kassam N, Ruffin N, Rottman JB, Sullivan N, et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro. J Exp Med. 1997;185:1681\u201391.","journal-title":"J Exp Med"},{"key":"4737_CR17","doi-asserted-by":"publisher","first-page":"e1148","DOI":"10.1016\/j.ijid.2013.06.009","volume":"17","author":"F Barmania","year":"2013","unstructured":"Barmania F, Potgiefer M, Pepper MS. Mutation in C-C chemoreceptor type 5 (CCR5) in south African individuals. Int J Infect Dis. 2013;17:e1148\u201353.","journal-title":"Int J Infect Dis"},{"key":"4737_CR18","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1084\/jem.185.4.621","volume":"185","author":"RI Connor","year":"1997","unstructured":"Connor RI, Sheridan KE, Ceradini S, Choe S, Landau NR. Change in coreceptor use correlates with disease progression in HIV-1 infected individuals. J Exp Med. 1997;185:621\u20138.","journal-title":"J Exp Med"},{"key":"4737_CR19","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/381667a0","volume":"381","author":"T Dragic","year":"1996","unstructured":"Dragic T, Litwin V, Allaway G, Martin SR, Huang Y, Nagashima KA, et al. HIV-1 entry into CD4+ cells in mediated by the chemokine receptor CCR5. Nature. 1996;381:667\u201373.","journal-title":"Nature"},{"key":"4737_CR20","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/381661a0","volume":"381","author":"H Deng","year":"1996","unstructured":"Deng H, Lin R, Ellmeier W, Choe S, Unutrnaz D, Burkhart M, et al. Identification of a major co-receptor for primary isolates of HIV-1. Nature. 1996;381:661\u20136.","journal-title":"Nature"},{"key":"4737_CR21","first-page":"877","volume":"872","author":"Y Feng","year":"1996","unstructured":"Feng Y, Broder CC, Kennedy PI, Berger EA. HIV-1 entry co-factor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science. 1996;872:877.","journal-title":"Science"},{"key":"4737_CR22","unstructured":"Khorramdelazad H, Bagheri V, Hassanshahi G, Zeinali M, Vakilian A. New insight into the role of stromal cell-derived factor 1 (SDF-1\/CXCL12) in the pathophysiology of multiple schlerosis."},{"key":"4737_CR23","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1159\/000449427","volume":"23","author":"MN Karimbadad","year":"2016","unstructured":"Karimbadad MN, Falahati-Pour SK, Hassanshabi G. Significant role(s) of CXCL12 and SDF-1 31A genetic variant in the pathophysiology of multiple sclerosis. Neuroimmunomodulation. 2016;23:197\u2013208.","journal-title":"Neuroimmunomodulation"},{"key":"4737_CR24","doi-asserted-by":"publisher","first-page":"6040","DOI":"10.1128\/JVI.72.7.6040-6047.1998","volume":"72","author":"NI Michael","year":"1998","unstructured":"Michael NI, Nelson JA, Kewal Ramani VN, Chang G, O\u2019Brien SJ, Mascola JR, et al. Exclusive and persistent use of the entry co-rector CxCR4 by human immunodeficiency virus type 1 form a subject homozygous for CCR5 delta 32. J Virol. 1998;72:6040\u20137.","journal-title":"J Virol"},{"key":"4737_CR25","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/ng0597-100","volume":"16","author":"JJ Martinson","year":"1997","unstructured":"Martinson JJ, Chapman NH, Rees DC, Liu YT, Clegg JB. Global distribution of the CCR5 gene 32 base pair deletion. Nat Genet. 1997;16:100\u20133.","journal-title":"Nat Genet"},{"key":"4737_CR26","volume-title":"A constitutional history of Nigeria","author":"BO Nwabueze","year":"1982","unstructured":"Nwabueze BO. A constitutional history of Nigeria. United Kingdom: C. Hurst and Co. LTD.; 1982."},{"key":"4737_CR27","unstructured":"Wikipedia, the free encyclopedia. Geography of Cross River State. Available at: https\/\/en.wikipedia.org\/wiki\/Cross_River_State . Accessed 27 May 2019."},{"key":"4737_CR28","volume-title":"Annual abstract of statistics 2011. NBS Federal Republic of Nigeria","author":"National Bureau of Statistics","year":"2011","unstructured":"National Bureau of Statistics. Annual abstract of statistics 2011. NBS Federal Republic of Nigeria 2011."},{"key":"4737_CR29","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1186\/s12913-019-4352-2","volume":"19","author":"HU Okoroiwu","year":"2019","unstructured":"Okoroiwu HU, Asemota EA. Blood donors deferral prevalence and causes in a tertiary health care hospital, southern Nigeria. BMC Health Serv Res. 2019;19:510.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"4737_CR30","first-page":"1","volume":"2","author":"OZ Kenneth","year":"2016","unstructured":"Kenneth OZ, Opuata S, Tatfeng YM TCA, Zaccheaus AJ. Null single nucleotide polymorphism in Cysteine \u2013 cysteine chemokine receptor 5 genes among Ijaw Etnic Population of Nigeria. Open J Blood Dis. 2016;2(3):1\u20136.","journal-title":"Open J Blood Dis"},{"issue":"11","key":"4737_CR31","doi-asserted-by":"publisher","first-page":"e339","DOI":"10.1371\/journal.pbio.0030339","volume":"3","author":"J Novembre","year":"2005","unstructured":"Novembre J, Galvani AP, Slatkin M. The geographic spread of the CCR5\u220632 HIV-resistance allele. Plos Biol. 2005;3(11):e339.","journal-title":"Plos Biol"},{"key":"4737_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.mrfmmm.2006.11.024","volume":"616","author":"AH Salem","year":"2007","unstructured":"Salem AH, Batzer MA. Distribution of the HIV resistance CCR5-delta 32 allele among Egytians and Syrians. Mutat Res. 2007;616:175\u201380.","journal-title":"Mutat Res"},{"key":"4737_CR33","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/sj.ejhg.5200568","volume":"8","author":"B Su","year":"2000","unstructured":"Su B, Sun G, Lu D, Xiao J, Hu F, Chakraborty R, Deka R, Jin L. Distribution of three HIV-1 resistance \u2013 conferring Polymorphisms (SDF1\u20133\u2019A, CCR2\u2013641 and CCR5 -\u220632) in global populations. Eur J Hum Genet. 2000;8:975\u20139.","journal-title":"Eur J Hum Genet"},{"key":"4737_CR34","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.micinf.2004.12.006","volume":"7","author":"AP Galvani","year":"2005","unstructured":"Galvani AP, November J. The evolutionary history of the CCR5-Delta 32 HIV-resistance mutation. Microbes Infect. 2005;7:302\u20139.","journal-title":"Microbes Infect"},{"key":"4737_CR35","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1365-2567.2012.03592.x","volume":"136","author":"ACP Picton","year":"2012","unstructured":"Picton ACP, Shalekoff S, Paximadis M, Tiemessen CT. Marked differences in CCR5 expression and activation levels in two South African Populations. Immunology. 2012;136:397\u2013407.","journal-title":"Immunology"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4737-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4737-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4737-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T19:09:25Z","timestamp":1609528165000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4737-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,3]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4737"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4737-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.12219\/v6","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.12219\/v5","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.12219\/v4","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.12219\/v3","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.12219\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.12219\/v1","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,3]]},"assertion":[{"value":"23 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by Health Research Ethical Committee (HREC) of the University of Calabar Teaching Hospital. Informed consent (written) was obtained from the study participants before commencing the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}